EP3045449A1 — Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
Assigned to Paratek Pharmaceuticals Inc · Expires 2016-07-20 · 10y expired
What this patent protects
The present invention pertains to tetracycline derivatives. These tetracycline derivatives can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, viral and parasitic infections as well as inflammatory disorders, such as …
USPTO Abstract
The present invention pertains to tetracycline derivatives. These tetracycline derivatives can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, viral and parasitic infections as well as inflammatory disorders, such as inflammatory disorders caused by radiation or trauma and inflammatory conditions of the skin.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.